Krüppel-like Factor 4 Promotes Differentiation by Transforming Growth Factor-beta Receptor-mediated Smad and P38 MAPK Signaling in Vascular Smooth Muscle Cells
Overview
Authors
Affiliations
KLF4 (Krüppel-like factor 4) has been implicated in vascular smooth muscle cell (VSMC) differentiation induced by transforming growth factor beta (TGF-beta). However, the role of KLF4 and mechanism of KLF4 actions in regulating TGF-beta signaling in VSMCs remain unclear. In this study, we showed that TGF-beta1 inhibited cell cycle progression and induced differentiation in cultured rat VSMCs. This activity of TGF-beta1 was accompanied by up-regulation of KLF4, with concomitant increase in TbetaRI (TGF-beta type I receptor) expression. KLF4 was found to transduce TGF-beta1 signals via phosphorylation-mediated activation of Smad2, Smad3, and p38 MAPK. The activation of both pathways, in turn, increased the phosphorylation of KLF4, which enabled the formation of KLF4-Smad2 complex in response to TGF-beta1. Chromatin immunoprecipitation studies and oligonucleotide pull-down assays showed the direct binding of KLF4 to the KLF4-binding sites 2 and 3 of the TbetaRI promoter and the recruitment of Smad2 to the Smad-responsive region. Formation of a stable KLF4-Smad2 complex in the promoter's Smad-responsive region mediated cooperative TbetaRI promoter transcription in response to TGF-beta1. These results suggest that KLF4-dependent regulation of Smad and p38 MAPK signaling via TbetaRI requires prior phosphorylation of KLF4 through Smad and p38 MAPK pathways. This study demonstrates a novel mechanism by which TGF-beta1 regulates VSMC differentiation.
Wang H, Guo S, Gao H, Ding J, Li H, Kong X J Clin Invest. 2024; 134(16).
PMID: 38889010 PMC: 11324308. DOI: 10.1172/JCI178303.
Targeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors.
Runa F, Ortiz-Soto G, de Barros N, Kelber J Pharmaceuticals (Basel). 2024; 17(3).
PMID: 38543112 PMC: 10975212. DOI: 10.3390/ph17030326.
Yu J, Yan W, Zhang X, Zheng B, Pan W, Yang Z J Geriatr Cardiol. 2023; 20(6):431-447.
PMID: 37416515 PMC: 10320774. DOI: 10.26599/1671-5411.2023.06.002.
New insights into KLFs and SOXs in cancer pathogenesis, stemness, and therapy.
Zeng L, Zhu Y, Moreno C, Wan Y Semin Cancer Biol. 2023; 90:29-44.
PMID: 36806560 PMC: 10023514. DOI: 10.1016/j.semcancer.2023.02.003.
Recent Advancements in Molecular Therapeutics for Corneal Scar Treatment.
Ghosh A, Singh V, Singh V, Basu S, Pati F Cells. 2022; 11(20).
PMID: 36291182 PMC: 9600986. DOI: 10.3390/cells11203310.